Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 5/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | HRH1 | P35367 | 5/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | SRC | P12931 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 2/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MTOR | P42345 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4275218 | 0.79 | GABBR2 (0.46) | HTR2ATAAR1HRH1CYP2D6SRC | |
| SCHEMBL4282489 | 0.77 | CES2 (0.42) | HTR2ATAAR1HRH1CYP2D6SRC | |
| SCHEMBL2096306 | 0.77 | HRH1 (0.56) | HTR2ATAAR1HRH1CYP2D6LMNA | |
| SCHEMBL94275 | 0.75 | HTR2A (0.52) | HTR2ATAAR1HRH1TDP1DPP4 | |
| SCHEMBL7331209 | 0.75 | HTR2A (0.52) | HTR2ATAAR1HRH1TDP1DPP4 | |
| SCHEMBL8609744 | 0.75 | TSHR (0.50) | HTR2ATAAR1HRH1CYP2D6SRC | |
| SCHEMBL9327547 | 0.75 | LMNA (0.58) | LMNARAB9AMAPK1 | |
| SCHEMBL709925 | 0.75 | TAAR1 (0.58) | TAAR1 | |
| SCHEMBL9838705 | 0.73 | HTR2A (0.58) | HTR2ATAAR1HRH1TDP1DPP4 | |
| SCHEMBL3290730 | 0.73 | HRH1 (0.68) | HTR2ATAAR1HRH1TDP1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118184973-A | Multifunctional CO2Base copolyester and preparation method thereof | 青岛科技大学 | 2024-06-14 | — | — | CN | claimed |
| CN-116375993-A | Simple method for preparing high molecular weight modifiable copolyester | 青岛科技大学 | 2023-07-04 | — | — | CN | claimed |
| CN-118206733-A | Controllable preparation method of high molecular weight polylactic acid | 青岛科技大学 | 2024-06-18 | — | — | CN | disclosed |
| US-20230322669-A1 | METHOD FOR PRODUCING PYRROLE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-10-12 | — | — | US | disclosed |
| EP-4257577-A2 | METHOD FOR PRODUCING PYRROLE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2023-10-11 | — | — | EP | disclosed |
| US-11649206-B2 | Method for producing pyrrole compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-05-16 | — | — | US | disclosed |
| US-20230143246-A1 | LIQUID PREPARATIONS OF AMINES AND ORGANIC ACIDS STABILIZED BY SALTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-05-11 | — | — | US | disclosed |
| US-20230088365-A1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-03-23 | — | — | US | disclosed |
| US-20220411449-A1 | Method for Preparing Heteroleptic Triarylbismuthanes and Compounds Produced by the Same | UNIVERSITY OF HAWAII | 2022-12-29 | — | — | US | disclosed |
| CN-114276524-A | Preparation method of high-molecular-weight degradable recyclable polyester containing double-bond side groups | 青岛科技大学 | 2022-04-05 | — | — | CN | disclosed |
| US-11254700-B2 | GSK-3β inhibitors and use thereof in methods of treatment | UNIVERSITY OF HAWAII (US) | 2022-02-22 | — | — | US | disclosed |
| WO-2001021577-A2 | MELANIN CONCENTRATING HORMONE ANTAGONIST | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-03-29 | — | — | WO | disclosed |
| EP-1063235-A1 | BENZOFURYLPYRONE DERIVATIVES | TEIJIN LIMITED (JP) | 2000-12-27 | — | — | EP | disclosed |
| EP-0868224-A1 | HEAT ABLATIVE COATING COMPOSITION | Ameron International Corporation (US) | 1998-10-07 | — | — | EP | disclosed |
| US-5703178-A | Heat ablative coating composition | AMERON INTERNATIONAL CORPORATION (US) | 1997-12-30 | — | — | US | disclosed |
| WO-1997019764-A1 | HEAT ABLATIVE COATING COMPOSITION | AMERON INTERNATIONAL CORPORATION (US) | 1997-06-05 | — | — | WO | disclosed |
| EP-0441226-A1 | (cyanomethyl)pyridines useful as PAF antagonists | J. URIACH & CIA. S.A. (ES) | 1991-08-14 | — | — | EP | disclosed |
| US-4359404-A | Hydrogenation of esters using alkali doped heterogeneous Group VIII transition metal catalysts | ALLIED CORPORATION (US) | 1982-11-16 | — | — | US | disclosed |
| US-4346240-A | Hydrogenation of esters using alkali doped heterogeneous group VIII transition metal catalysts | ALLIED CORPORATION (US) | 1982-08-24 | — | — | US | disclosed |
| EP-0036939-A1 | Hydrogenation of esters using alkali doped heterogeneous group VIII transition metal catalysts | ALLIED CORPORATION (US) | 1981-10-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220411449-A1 | Method for Preparing Heteroleptic Triarylbismuthanes and Compounds Produced by the Same | COASY, HAGH, MRM1 | HTR2A 4394/4885TAAR1 2287/4885HRH1 2687/4885 |
| US-20230088365-A1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | DHPS, STS, HPD | HTR2A 2670/4885TAAR1 4240/4885HRH1 1851/4885 |
| US-11254700-B2 | GSK-3β inhibitors and use thereof in methods of treatment | GSK3B, GSK3A, GSKIP | HTR2A 3317/4885TAAR1 4549/4885HRH1 4208/4885 |
| US-20230143246-A1 | LIQUID PREPARATIONS OF AMINES AND ORGANIC ACIDS STABILIZED BY SALTS | OTC, SLC38A7, SRI | HTR2A 416/4885TAAR1 314/4885HRH1 171/4885 |
| US-20230322669-A1 | METHOD FOR PRODUCING PYRROLE COMPOUND | HPD, PPOX, CBR3 | HTR2A 2083/4885TAAR1 3649/4885HRH1 68/4885 |
| US-11649206-B2 | Method for producing pyrrole compound | HPD, PPOX, CBR3 | HTR2A 2083/4885TAAR1 3649/4885HRH1 68/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.